• Explore /
  • Poster
  • / Cisplatin-based neoadjuvant chemotherapy (NAC) in bladder cancer patients (Pts) with borderline renal function: Implications for clinical practice.

Cisplatin-based neoadjuvant chemotherapy (NAC) in bladder cancer patients (Pts) with borderline renal function: Implications for clinical practice.

Abstract Poster

Authors

null

Vadim S. Koshkin

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Vadim S. Koshkin , Pedro C. Barata , Haris Zahoor , Lisa A. Rybicki , Hamid Emamekhoo , Nima Almassi , Katherine Tullio , Alicia M Redden , Amr Farouk Fergany , Jihad Kaouk , Georges-Pascal Haber , Jennifer Beach , Allison Martin , Kimberly D Allman , Jorge A. Garcia , Timothy D. Gilligan , Brian I. Rini , Petros Grivas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Prostate Cancer,Urothelial Carcinoma,Prostate Cancer

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 390)

DOI

10.1200/JCO.2017.35.6_suppl.390

Abstract #

390

Poster Bd #

J3

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer.

Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer.

First Author: Marshall Strother

First Author: Elizabeth R. Plimack

First Author: Catherine Curran

First Author: Benjamin Miron